Results 91 to 100 of about 12,742 (223)
Epilepsia Open, EarlyView.Abstract Objective Artificial intelligence (AI)‐powered chatbots are increasingly used for patient education and mental health support, yet their effectiveness in epilepsy care remains underexplored. This study examines text‐based interactions between users and EpiloBot, an epilepsy‐focused chatbot, to understand conversational patterns and emotional ...
Keiichi Watanuki +10 more
wiley +1 more source
Pediatric Neurology Briefs, 1997 Two unrelated families with X-linked infantile spasm syndrome were studied genetically by two-point and multipoint linkage analyses at the University Hospital Gasthuisberg, and Center for Human Genetics, University of Leuven, and University of Antwerp ...
J Gordon Millichap
doaj +1 more source
Pharmacotherapy in patients with epilepsy and psychosis. [PDF]
, 2018 The recognition and treatment of psychosis in persons with epilepsy (PWE) is recommended with the apparent dilemma between treating psychosis and opening the possibility of exacerbating seizures. The pooled prevalence estimate of psychosis in PWE is 5.6%.
Adachi, N +9 more
core +1 more source
Epilepsia Open, EarlyView.Abstract Objective Ketogenic dietary therapies (KDTs) are the treatment of choice for Glut1 Deficiency Syndrome (Glut1DS), providing dietary ketones as an alternative fuel to the brain and effectively controlling seizures. Recent evidence indicates insufficient seizure control in Glut1DS patients despite adequate KDT and ketosis.
Joerg Klepper, Eva Runkel, Lucia Kiesel
wiley +1 more source
Trends in antiseizure medication monotherapy for pediatric epilepsy in the United States
Epilepsia Open, EarlyView.Abstract Objective National prescribing trends for antiseizure medication (ASM) in children with epilepsy over the past decade are unclear. Despite the 2021 SANAD II trials supporting lamotrigine and valproate for focal and generalized epilepsies, respectively, it is unknown if their use increased.
Adam P. Ostendorf +6 more
wiley +1 more source
Lafora Disease Masquerading as Hepatic Dysfunction [PDF]
, 2018 Lafora disease is fatal intractable progressive myoclonic epilepsy. It is frequently characterized by epileptic seizures, difficulty walking, muscle spasms, and dementia in late childhood or adolescence.
Abdullah, Hafez Mohammad A. +6 more
core +1 more source
Tratamento da epilepsia mioclônica juvenil com topiramato [PDF]
, 2005 OBJECTIVE: The aim of this study was to evaluate the efficacy and tolerability of topiramate (TPM) in juvenile myoclonic epilepsy (JME). METHOD: We assessed seizure control and adverse effects of TPM in 22 patients (18 females) aged 13 to 53 years ...
Araujo Filho, Gerardo Maria de +4 more
core +2 more sources
Convergence Deficits in Myoclonus‐Dystonia Point to Cerebellar Impairment
Movement Disorders Clinical Practice, EarlyView.Abstract Background Myoclonus‐dystonia (M‐D) is a monogenic movement disorder, with proposed cerebellar dysfunction. Vergence eye movement deficits, characteristics of degenerative cerebellar disease, have not been studied in M‐D. Cerebellar transcranial alternating current stimulation (tACS) is considered a potential therapeutic approach.
Skadi Gerkensmeier +13 more
wiley +1 more source
The Effect of Zonisamide on Sex Hormones Level and Testis Histological Changes in Adult MaleRat
Armaghane Danesh Bimonthly Journal, 2014 Background and aim: Zonisamide is an inhibitor for glutamate neurotransmitter and gamma aminobutiric acid (GABA)-mediators. It also increases the total levels of serotonin.
M Mallaki, M Shariati, L Sepehrara
doaj
The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis [PDF]
, 2017 People with severe mental illness (SMI) have reduced life expectancy compared with the general population, which can be explained partly by their increased risk of diabetes.
A Amrami-Weizman +94 more
core +6 more sources